-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $3.5

Benzinga·03/04/2026 15:31:10
Listen to the news
Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $7 to $3.5.